作者：
Katharine L,Lewis [1]
;
Lasse H,Jakobsen [2]
;
Diego,Villa [3]
;
Karin E,Smedby [4]
;
Kerry J,Savage [5]
;
Toby A,Eyre [6]
;
Kate,Cwynarski [5]
;
Mark J,Bishton [7]
;
Christopher P,Fox [8]
;
Eliza A,Hawkes [9]
;
Matthew J,Maurer [10]
;
Tarec C,El-Galaly [9]
;
Chan Y,Cheah [10]
;
International CNS Prophylaxis Study Group [11]
作者单位：
Linear Clinical Research, Nedlands, WA, Australia.
[1]
Division of Haematology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.
[2]
Division of Internal Medicine, Medical School, University of Western Australia, Perth, WA, Australia.
[3]
Department of Haematology, Aalborg University Hospital, Aalborg, Denmark.
[4]
BC Cancer Centre for Lymphoid Cancer, The University of British Columbia, Vancouver, BC, Canada.
[5]
Department of Medicine Solna, Division of Clinical Epidemiology, Karolinska Institutet, Stockholm, Sweden.
[6]
Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
[7]
University College London Hospital NHS Foundation Trust, London, United Kingdom.
[8]
Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
[9]
University of Nottingham, Nottingham, United Kingdom.
[10]
Olivia Newton-John Cancer Research & Wellness Centre at Austin Health, Heidelberg, VIC, Australia.
[11]
Monash University School of Public Health and Preventive Medicine, Melbourne, VIC, Australia.
[12]
Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN.
[13]
Department of Haematology, PathWest, Nedlands, WA, Australia.
[14]
DOI
10.1200/JCO.23.00365
PMID
37797284
发布时间
2024-01-04
换一批
换一批
